Sort
78,016 grants matching “breast cancer”
Cell Cycle/Apoptosis Gene Variants and Breast Cancer Risk
$515,157Qiuyin Cai · Vanderbilt University · R01 · FY2011 · CA
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$515,141Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
DAP5-dependent translational control and breast cancer metastasis
$515,131Robert Schneider · New York University School Of Medicine · R01 · FY2021 · CA
DAP5-dependent translational control and breast cancer metastasis
$515,131Robert Schneider · New York University School Of Medicine · R01 · FY2020 · CA
Implementation Research Training Program in Cancer Prevention and Control
$515,129Stephenie C. Lemon · Univ Of Massachusetts Med Sch Worcester · R25 · FY2017 · CA
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$515,103Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
MECHANISTIC AND THERAPEUTIC IMPLICATIONS OF SPLICEOSOMAL GENE MUTATIONS IN ER+ BREAST CANCER
$515,100Sloan-Kettering Institute For Cancer Research · · FY2018 · Department of the Army
MECHANISTIC AND THERAPEUTIC IMPLICATIONS OF SPLICEOSOMAL GENE MUTATIONS IN ER+ BREAST CANCER
$515,100Sloan-Kettering Institute For Cancer Research · · FY2018 · Department of the Army
ROLE OF PLEIOTROPHIN IN BREAST CANCER
$515,086Scripps Research Institute · R01 · FY2003 · CA
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
$515,071Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2016 · CA
NANOPARTICLE SELF-LIGHTING PHOTODYNAMIC THERAPY FOR BREAST CANCER TREATMENT
$515,036University Of Texas At Arlington · · FY2010 · Department of Defense
Ultrasonic assessment of therapeutic response
$514,963Katherine W Ferrara · University Of California At Davis · R01 · FY2010 · CA
Meiotic Interactions of the RecA Homologue Dmc1
$514,944Douglas K. Bishop · University Of Chicago · R01 · FY2013 · GM
UTILIZATION OF PERSONALIZED MEDICINE USING GENOMICS
$514,902Jennifer S Haas · University Of California, San Francisco · P01 · FY2008 · CA
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$514,902Donald P McDonnell · Duke University · R01 · FY2024 · CA
RENEW Research-out to ENhancE Wellness Older Survivors
$514,890Wendy Demark-Wahnefried · Duke University · R01 · FY2006 · CA
Epigenetic Alterations and Targeted Therapies in North American ATLL
$514,837Bihui Hilda Ye · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Fatty Acylation of Hedgehog and Wnt Proteins
$514,817Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2017 · GM
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
$514,791David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Project 2: Optimizing polygenic risk scores to inform breast cancer screening and prevention
$514,780Yiwey Shieh · University Of California, San Francisco · P01 · FY2025 · CA
Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia
$514,712E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia
$514,712E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
An ensemble deep learning model for tumor bud detection and risk stratification in colorectal carcinoma.
$514,691Wei Chen · Ohio State University · R01 · FY2024 · CA
Mis-Implementation in Cancer Prevention and Control
$514,690Ross C Brownson · Washington University · R01 · FY2020 · CA
Accuracy of Physical Activity Measures in Cancer Studies
$514,623Barbara Sternfeld · Kaiser Foundation Research Institute · R01 · FY2007 · CA